Alpha Cognition Inc (TSE:ACOG) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Alpha Cognition Inc. has announced the partial exercise of its over-allotment option, resulting in the sale of an additional 488,506 shares at $5.75 per share, raising an extra $2.8 million in gross proceeds. In total, the company sold over 9 million shares, generating approximately $52.8 million to support the commercialization of its Alzheimer’s drug ZUNVEYL and further research. The shares, trading under the ticker ACOG on Nasdaq, aim to bolster the company’s resources for advancing its neurodegenerative treatment pipeline.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
